Case Report: HCV-triggered porphyria cutanea tarda in a patient with SEC23B-mutated congenital dyserythropoietic anemia type II - Summary - MDSpire

Case Report: HCV-triggered porphyria cutanea tarda in a patient with SEC23B-mutated congenital dyserythropoietic anemia type II

  • By

  • Xianghong Jin

  • Yixuan Li

  • Yaping Liu

  • Xianyong Jiang

  • Junling Zhuang

  • Min Shen

  • Miao Chen

  • July 13, 2026

Share

Objective:

To report a case of porphyria cutanea tarda (PCT) triggered by hepatitis C virus (HCV) in a patient with congenital dyserythropoietic anemia type II (CDA II) due to SEC23B mutations.

Approach:
  • Case Presentation: A 34-year-old male with SEC23B-mutated CDA II developed photosensitive bullae associated with chronic HCV genotype 1b infection, hyperbilirubinemia, and severe iron overload.
Key Findings:
  • The patient had compound heterozygous SEC23B mutations causing CDA II.
  • HCV infection was confirmed, and urinary porphyrins were positive.
  • Treatment with sofosbuvir/velpatasvir resulted in undetectable HCV RNA and resolution of skin lesions.
Interpretation:

The case illustrates the interplay of genetic, viral, and environmental factors in triggering PCT in patients with CDA II.

Limitations:
  • UROD activity was not directly measured in the patient.
  • The mechanistic model is based on established molecular knowledge rather than experimental data.
Conclusion:

This case highlights the importance of recognizing combined genetic and infectious factors in rare hematologic disorders.

Original Source(s)

Related Content